Dehidrobenzperidol en es it fr

Dehidrobenzperidol Brand names, Dehidrobenzperidol Analogs

Dehidrobenzperidol Brand Names Mixture

  • No information avaliable

Dehidrobenzperidol Chemical_Formula


Dehidrobenzperidol RX_link

Dehidrobenzperidol fda sheet

Dehidrobenzperidol msds (material safety sheet)

Dehidrobenzperidol MSDS

Dehidrobenzperidol Synthesis Reference

No information avaliable

Dehidrobenzperidol Molecular Weight

166.24 g/mol

Dehidrobenzperidol Melting Point

No information avaliable

Dehidrobenzperidol H2O Solubility

Appreciable as liquid hydrochloride salt

Dehidrobenzperidol State


Dehidrobenzperidol LogP


Dehidrobenzperidol Dosage Forms

Liquid for injection

Dehidrobenzperidol Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Dehidrobenzperidol Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Dehidrobenzperidol Absorption

Rapidly absorbed.

Dehidrobenzperidol side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Dehidrobenzperidol Patient Information

No information avaliable

Dehidrobenzperidol Organisms Affected

Humans and other mammals